Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 6Fatigue 6Breast Neoplasms 5Anxiety Disorders 3Psychological Well-Being 2Pain 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Caregiver Burden 2Uterine Neoplasms 1Tuberous Sclerosis 1Substance-Related Disorders 1Smoking Cessation 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasm Regression, Spontaneous 1Multiple Myeloma 1Malignant Hepatobiliary Neoplasm 1Lymphoma 1Leukemia 1Hematopoietic Cell Transplantation Recipient 1Head and Neck Neoplasms 1

Interventions

AZD 6244 10trametinib 4pirfenidone 3dabrafenib 2cabozantinib 2Imatinib Mesylate 2tipifarnib 1peginterferon alfa-2b 1nilotinib 1mirdametinib 1cediranib 1binimetinib 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Pharmacokinetics 1Methotrexate 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Cryotherapy 1Control Groups 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neurofibroma, Plexiform × Acceptance and Commitment Therapy × Clear all
NCT02471339 2022-06-14

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
66 enrolled 17 charts
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡